Prevention & Control
15
0
0
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
20%
3 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (15)
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children
Impact of Prevention of Safe Sleeping and Unexpected Infant Death
Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease
Substantivity of Oral Rinses: Comparative Study
S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections
Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)
Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy
Effects Provided by a Physiotherapy Treatment Preventing Lower Extremity Injuries in Female Football Players
Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy
Cohort Study of Risk Reducing Salpingectomy
Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever
KAN-DO: A Family-based Intervention to Prevent Childhood Obesity
Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients
Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders